MDGH Project Team
MDGH is a not-for-profit pharmaceutical company dedicated to the development of medicines for those who need them most.
Our Team
Medicine Development for Global Health (MDGH) is a not-for-profit pharmaceutical company whose project team is composed of dedicated researchers and professionals committed to advancing the objectives of the EMINENCE project. Bringing together expertise in clinical development, public health, regulatory science, and other key disciplines, the team plays a crucial role in implementing innovative strategies to combat neglected tropical diseases. Through rigorous research, fieldwork, and global collaboration, MDGH contributes to strengthening disease surveillance, improving access to affordable treatments, and supporting international efforts to eliminate onchocerciasis.
Prof. Mark Sullivan
Ms. Sally Kinrade
Main contact person
Medicine Development for Global Health (MDGH) is an independent, not-for-profit organisation dedicated to developing and delivering affordable, high-quality medicines that address urgent global health needs. Focused on diseases such as onchocerciasis, tuberculosis, and other neglected conditions, MDGH contributes to advancing equitable access to essential treatments through innovative partnerships and rigorous clinical development.
Mark Sullivan, Founder and Managing Director of MDGH, serves as the principal contact for the EMINENCE project, overseeing the organisation’s scientific contributions and strategic engagement within the consortium.
About Us
The EMINENCE project is dedicated to eliminating onchocerciasis in Africa through innovative clinical research and the evaluation of moxidectin to enhance disease control and accelerate eradication efforts.
Useful Links:
Social Media
© EMINENCE - EDCTP. All rights reserved